Date Approved

2020

Date Posted

2-16-2021

Degree Type

Open Access Thesis

Degree Name

Master of Science (MS)

Department

Health Sciences

Committee Member

Irwin Martin, Ph.D., Chair

Committee Member

Jean Rowan, M.D., M.S.

Abstract

This study analyzed drugs and biologics recalls for the period of 2009 and 2019. The data used in the study was generated from Food and Drug Administration records. A total of 466 drugs and 84 biologics were recalled during the 11-year period. The common causes of drug product recalls included contamination, defective products, and mislabeling. Defective product, mislabeling, and defective packaging were observed to be the common causes of recall for biologics. Injectables have the highest percentage of recalls in drug products, and blood and blood products had the highest percentage of recalls in biologics. Controlling the contamination of injectable and also minimizing mislabeling, defective packaging and defective product of blood and blood products could help in providing safer drugs and biologics to the public.

Share

COinS